arginine and norfloxacin

arginine has been researched along with norfloxacin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	3 (50.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chin-Dusting, J; Colman, J; Kemp, W; Kompa, A; Krum, H; Madan, A; Roberts, S; Thompson, K; Vincent, M	1
Bafna, JA; Bhamidimarri, SP; Wang, J; Winterhalter, M	1
Cai, D; Huang, X; Lei, H; Li, T; Lu, J; Tian, X; Wang, P; Xu, B; Yang, X; Yang, Y; Yuan, Z; Zhang, Y	1

Reviews

1 review(s) available for arginine and norfloxacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for arginine and norfloxacin

Article	Year
Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Arginine; Cross-Over Studies; Endotoxemia; Humans; Hypertension, Portal; Liver Cirrhosis; Norfloxacin; Portal Pressure; Statistics, Nonparametric; Urotensins; Victoria	2009

Article

Year

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial.

Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:3

Topics: Anti-Bacterial Agents; Arginine; Cross-Over Studies; Endotoxemia; Humans; Hypertension, Portal; Liver Cirrhosis; Norfloxacin; Portal Pressure; Statistics, Nonparametric; Urotensins; Victoria

2009

Other Studies

4 other study(ies) available for arginine and norfloxacin

Article	Year
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:2 Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism	1999
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Small-Molecule Permeation across Membrane Channels: Chemical Modification to Quantify Transport across OmpF. Angewandte Chemie (International ed. in English), 2019, 03-26, Volume: 58, Issue:14 Topics: Anti-Bacterial Agents; Arginine; Cysteine; Ion Channels; Norfloxacin; Peptides; Porins; Small Molecule Libraries	2019
Injectable Carrier-Free Hydrogel Dressing with Anti-Multidrug-Resistant ACS applied materials & interfaces, 2022, Sep-28, Volume: 14, Issue:38 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arginine; Bandages; Humans; Hydrogels; Interleukin-6; Methicillin-Resistant Staphylococcus aureus; Norfloxacin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Tetracycline; Tumor Necrosis Factor-alpha; Wound Healing; Wound Infection	2022